KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $236.0 million.

  • Elevance Health's Cash from Financing Activities fell 8323.86% to $236.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.7 billion, marking a year-over-year decrease of 24568.32%. This contributed to the annual value of -$1.7 billion for FY2025, which is 24568.32% down from last year.
  • Elevance Health's Cash from Financing Activities amounted to $236.0 million in Q4 2025, which was down 8323.86% from $243.0 million recorded in Q3 2025.
  • Elevance Health's 5-year Cash from Financing Activities high stood at $3.4 billion for Q1 2021, and its period low was -$1.9 billion during Q1 2025.
  • Its 5-year average for Cash from Financing Activities is -$239.4 million, with a median of -$351.0 million in 2023.
  • Per our database at Business Quant, Elevance Health's Cash from Financing Activities surged by 45736.04% in 2024 and then tumbled by 606562.5% in 2025.
  • Elevance Health's Cash from Financing Activities (Quarter) stood at -$1.3 billion in 2021, then skyrocketed by 80.38% to -$258.0 million in 2022, then tumbled by 52.71% to -$394.0 million in 2023, then soared by 457.36% to $1.4 billion in 2024, then crashed by 83.24% to $236.0 million in 2025.
  • Its last three reported values are $236.0 million in Q4 2025, $243.0 million for Q3 2025, and -$308.0 million during Q2 2025.